3Coiletti LM.Ischemia reperfution and inflammatory cytokine cascades//Greenfield LJ.Surgery.3rd ed.Philadelphia:Lippincott,2001:130-131.
4Hart G K,Dobb G J.Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill.JPEN J Parenter Enteral Nutr,1988,12 (5):465-468.
5Knaus WA,Draper EA,Wagner JP,et al.APACHE Ⅱ:a Severity of disease classification system.Crit Care Med,1985,13:818-829.
6Fink MP,Delute RL.Epithelial barrier dysfunction:a unifying theme to explain the path ogenesis of multiple organ dysfunction at the cellular level.Crit Care Clin,2005,21:177-196.
7Nguyen N Q,Ching K,Fraser R J,et al.Risk of clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance.Intensive Care Med,2008,34(1):169-173.
8Knaus W A,Draper E A,Wagner D P,et al.APACHE II:A Severity of Disease Classification System[ J ].Crit Care Med, 1985,13(10) : 818-829.
9Hart G K, Dobb G J. Effect of a Fecal BuLking Agent on Diarrhea during Eenteral Feeding in the Critically lll[J ]. JPEN J Parenter Enteral Nutr, 1988,12(5):465-468.
10Plunkett AR, Shields C, Stojadinovic A, et al.Awake thyroidectomy un- der local anesthesia and dexmedetomidine infusion [J ].Mil Med, 2009, 174(1 ) : 100-102.
